Skip to main content

Pfizer Constructs Irish Biotech and R&D Facilities

Published 5/7/2008

Pfizer is constructing two facilities in County Cork, Ireland. A $297 million biopharmaceutical clinical manufacturing plant in Shanbally will produce experimental medicines for Phase II and III clinical trials. An R&D center housing 100 employees will be built at Pfizer’s existing campus in Ringaskiddy. Both projects are slated for completion by year-end 2009.